Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15265 | 722 | 32.3 | 54% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
206 | 3 | JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION//DENGUE//WEST NILE VIRUS | 52352 |
305 | 2 | WEST NILE VIRUS//FLAVIVIRUS//DENGUE VIRUS | 18516 |
15265 | 1 | YELLOW FEVER//YELLOW FEVER VACCINE//YELLOW FEVER VIRUS | 722 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | YELLOW FEVER | authKW | 3150697 | 21% | 50% | 150 |
2 | YELLOW FEVER VACCINE | authKW | 1717526 | 8% | 71% | 57 |
3 | YELLOW FEVER VIRUS | authKW | 1004481 | 7% | 49% | 48 |
4 | VISCEROTROPIC DISEASE | authKW | 338331 | 1% | 100% | 8 |
5 | TECNOL IMUNOBIOL | address | 246219 | 3% | 31% | 19 |
6 | 17D VACCINE | authKW | 230250 | 1% | 78% | 7 |
7 | YELLOW FEVER VACCINATION | authKW | 207224 | 1% | 70% | 7 |
8 | 17D | authKW | 190308 | 1% | 75% | 6 |
9 | 17D STRAIN | authKW | 169166 | 1% | 100% | 4 |
10 | YELLOW FEVER VACCINE ASSOCIATED VISCEROTROPIC DISEASE | authKW | 169166 | 1% | 100% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Tropical Medicine | 14584 | 21% | 0% | 154 |
2 | BIOLOGY, MISCELLANEOUS | 8868 | 2% | 1% | 18 |
3 | Virology | 5634 | 21% | 0% | 155 |
4 | Immunology | 1690 | 24% | 0% | 175 |
5 | Public, Environmental & Occupational Health | 1553 | 20% | 0% | 143 |
6 | Infectious Diseases | 1068 | 12% | 0% | 87 |
7 | Parasitiology | 835 | 7% | 0% | 49 |
8 | Medicine, Research & Experimental | 575 | 11% | 0% | 83 |
9 | Biotechnology & Applied Microbiology | 226 | 9% | 0% | 64 |
10 | Microbiology | 146 | 7% | 0% | 53 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TECNOL IMUNOBIOL | 246219 | 3% | 31% | 19 |
2 | BIOL MOL FLAVIVIRUS | 114286 | 1% | 27% | 10 |
3 | ARBOVIROL VIRAL HEMORRHAG FEVER | 84583 | 0% | 100% | 2 |
4 | MED INVEST LIM 3 | 84583 | 0% | 100% | 2 |
5 | NUCLEO POS CIENCIAS BIOL | 84583 | 0% | 100% | 2 |
6 | TECNOL VIROL LATEV | 84583 | 0% | 100% | 2 |
7 | EVANDRO CHAGAS | 67360 | 3% | 8% | 20 |
8 | DIRETORIA REG BRASILIA DIREB | 56387 | 0% | 67% | 2 |
9 | GLOBAL ALERT PONSE HSE GAR | 56387 | 0% | 67% | 2 |
10 | SERV MED INTERNE TROP | 56387 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF BIOLOGICAL STANDARDIZATION | 33143 | 2% | 4% | 18 |
2 | BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE | 13680 | 3% | 1% | 23 |
3 | ANNALES DE VIROLOGIE | 12692 | 1% | 4% | 8 |
4 | VACCINE | 9853 | 9% | 0% | 65 |
5 | AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 8667 | 6% | 0% | 46 |
6 | JOURNAL OF TRAVEL MEDICINE | 7307 | 2% | 1% | 15 |
7 | TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 3236 | 3% | 0% | 23 |
8 | BIOLOGICALS | 3092 | 1% | 1% | 10 |
9 | JOURNAL OF GENERAL VIROLOGY | 3004 | 4% | 0% | 31 |
10 | BULLETIN OF THE WORLD HEALTH ORGANIZATION | 2412 | 2% | 0% | 14 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | YELLOW FEVER | 3150697 | 21% | 50% | 150 | Search YELLOW+FEVER | Search YELLOW+FEVER |
2 | YELLOW FEVER VACCINE | 1717526 | 8% | 71% | 57 | Search YELLOW+FEVER+VACCINE | Search YELLOW+FEVER+VACCINE |
3 | YELLOW FEVER VIRUS | 1004481 | 7% | 49% | 48 | Search YELLOW+FEVER+VIRUS | Search YELLOW+FEVER+VIRUS |
4 | VISCEROTROPIC DISEASE | 338331 | 1% | 100% | 8 | Search VISCEROTROPIC+DISEASE | Search VISCEROTROPIC+DISEASE |
5 | 17D VACCINE | 230250 | 1% | 78% | 7 | Search 17D+VACCINE | Search 17D+VACCINE |
6 | YELLOW FEVER VACCINATION | 207224 | 1% | 70% | 7 | Search YELLOW+FEVER+VACCINATION | Search YELLOW+FEVER+VACCINATION |
7 | 17D | 190308 | 1% | 75% | 6 | Search 17D | Search 17D |
8 | 17D STRAIN | 169166 | 1% | 100% | 4 | Search 17D+STRAIN | Search 17D+STRAIN |
9 | YELLOW FEVER VACCINE ASSOCIATED VISCEROTROPIC DISEASE | 169166 | 1% | 100% | 4 | Search YELLOW+FEVER+VACCINE+ASSOCIATED+VISCEROTROPIC+DISEASE | Search YELLOW+FEVER+VACCINE+ASSOCIATED+VISCEROTROPIC+DISEASE |
10 | 17DD STRAIN | 126874 | 0% | 100% | 3 | Search 17DD+STRAIN | Search 17DD+STRAIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MONATH, TP , VASCONCELOS, PFC , (2015) YELLOW FEVER.JOURNAL OF CLINICAL VIROLOGY. VOL. 64. ISSUE . P. 160 -173 | 70 | 90% | 23 |
2 | BEASLEY, DWC , MCAULEY, AJ , BENTE, DA , (2015) YELLOW FEVER VIRUS: GENETIC AND PHENOTYPIC DIVERSITY AND IMPLICATIONS FOR DETECTION, PREVENTION AND THERAPY.ANTIVIRAL RESEARCH. VOL. 115. ISSUE . P. 48 -70 | 113 | 60% | 12 |
3 | DOMINGO, C , NIEDRIG, M , (2009) SAFETY OF 17D DERIVED YELLOW FEVER VACCINES.EXPERT OPINION ON DRUG SAFETY. VOL. 8. ISSUE 2. P. 211-221 | 49 | 83% | 13 |
4 | MONATH, TP , (2012) REVIEW OF THE RISKS AND BENEFITS OF YELLOW FEVER VACCINATION INCLUDING SOME NEW ANALYSES.EXPERT REVIEW OF VACCINES. VOL. 11. ISSUE 4. P. 427 -448 | 54 | 62% | 36 |
5 | AMANNA, IJ , SLIFKA, MK , (2016) QUESTIONS REGARDING THE SAFETY AND DURATION OF IMMUNITY FOLLOWING LIVE YELLOW FEVER VACCINATION.EXPERT REVIEW OF VACCINES. VOL. 15. ISSUE 12. P. 1519 -1533 | 54 | 66% | 0 |
6 | THOMAS, RE , LORENZETTI, DL , SPRAGINS, W , JACKSON, D , WILLIAMSON, T , (2011) ACTIVE AND PASSIVE SURVEILLANCE OF YELLOW FEVER VACCINE 17D OR 17DD-ASSOCIATED SERIOUS ADVERSE EVENTS: SYSTEMATIC REVIEW.VACCINE. VOL. 29. ISSUE 28. P. 4544 -4555 | 42 | 88% | 15 |
7 | THOMAS, RE , (2016) YELLOW FEVER VACCINE-ASSOCIATED VISCEROTROPIC DISEASE: CURRENT PERSPECTIVES.DRUG DESIGN DEVELOPMENT AND THERAPY. VOL. 10. ISSUE . P. 3345 -3353 | 39 | 87% | 0 |
8 | GOTUZZO, E , YACTAYO, S , CORDOVA, E , (2013) REVIEW ARTICLE: EFFICACY AND DURATION OF IMMUNITY AFTER YELLOW FEVER VACCINATION: SYSTEMATIC REVIEW ON THE NEED FOR A BOOSTER EVERY 10 YEARS.AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. VOL. 89. ISSUE 3. P. 434-444 | 36 | 84% | 28 |
9 | COTTIN, P , NIEDRIG, M , DOMINGO, C , (2013) SAFETY PROFILE OF THE YELLOW FEVER VACCINE STAMARIL (R): A 17-YEAR REVIEW.EXPERT REVIEW OF VACCINES. VOL. 12. ISSUE 11. P. 1351-1368 | 38 | 79% | 13 |
10 | TOMORI, O , (2004) YELLOW FEVER: THE RECURRING PLAGUE.CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 41. ISSUE 4. P. 391-427 | 42 | 86% | 57 |
Classes with closest relation at Level 1 |